EcoDrugPlus

Emap Like 4

Ensembl ID : ENSSPAG00000006058
Gene Symbol: EML4
4 Cross references
207 Possible Orthologues:

Eph Receptor A3

Ensembl ID : ENSSPAG00000013788
Gene Symbol: EPHA3
1 Cross references
208 Possible Orthologues:

Fau Ubiquitin Like And Ribosomal Protein S30 Fusion

Ensembl ID : ENSSPAG00000000157
Gene Symbol: FAU
3 Cross references
300 Possible Orthologues:

G Protein-Coupled Receptor 119

Ensembl ID : ENSSPAG00000005440
Gene Symbol: GPR119
4 Cross references
174 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSSPAG00000013270
Gene Symbol: HCK
3 Cross references
202 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSSPAG00000014914
Gene Symbol: ITK
3 Cross references
205 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSSPAG00000015004
Gene Symbol: JAK1
3 Cross references
212 Possible Orthologues:

Janus Kinase 2

Ensembl ID : ENSSPAG00000005276
Gene Symbol: JAK2
3 Cross references
199 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSSPAG00000009928
Gene Symbol: KRAS
3 Cross references
207 Possible Orthologues:

Lyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSSPAG00000002251
Gene Symbol: LYN
3 Cross references
195 Possible Orthologues:

Malt1 Paracaspase

Ensembl ID : ENSSPAG00000013644
Gene Symbol: MALT1
3 Cross references
195 Possible Orthologues:

Map Kinase-Activated Protein Kinase 2-Like

Ensembl ID : ENSSPAG00000002727
Gene Symbol: LOC103374533
2 Cross references
170 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).